Health Care: Drugs

Regulus Therapeutics Inc (RGLS: NASDAQ)

$7.55 -0.35 | -4.43%
09/15/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011
Sales 19.57M 12.70M 13.79M
Cost of Sales 0.00 0.00 0.00
Gross Operating Profit 19.57M 12.70M 13.79M
Selling, General, and Administrative Expenses 7.43M 4.93M 3.64M
Research & Development 29.94M 20.34M 17.29M
Operating Income before D & A (EBITDA) -17.80M -12.57M -7.14M
Depreciation & Amortization 2.82M 1.44M 1.46M
Interest Income 292.00K 110.00K 128.00K
Other Income - Net -1.14M -4.71M 1.00K
Special Income / Charges 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -21.48M -18.61M -8.47M
Interest Expense 36.00K 247.00K 388.00K
Pre-Tax Income -21.52M -18.86M -8.86M
Income Taxes -23.00K -10.00K 206.00K
Minority Interest 0.00 0.00 0.00
Net Income From Continuing Operations -18.67M -17.41M -7.60M
Net Income From Discontinued Operations 0.00 0.00 0.00
Net Income From Total Operations -18.67M -17.41M -7.60M
Extraordinary Income/Losses 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00
Total Net Income -18.67M -17.41M -7.60M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-18.67M -17.41M -7.60M
Preferred Dividends
Net Income Available To Common -18.67M -17.41M -7.60M
Basic EPS from Continuing Ops. -0.49 -2.12 -0.50
Basic EPS from Discontinued Ops. 0.00 0.00 0.00
Basic EPS from Total Operations -0.49 -2.12 -0.50
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.01
Basic EPS, Total -0.49 -2.12 -0.49
Basic Normalized Net Income/Share -0.49 -2.12 -0.50
EPS fr Continuing Ops. -0.49 -2.12 -0.50
EPS fr Discontinued Ops 0.00 0.00 0.00
EPS fr Total Ops. -0.49 -2.12 -0.50
EPS fr Extraord. Inc. 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.01
EPS, Total -0.49 -2.12 -0.49
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.49 -2.12 -0.50
Dividends Paid per Share 0.00 0.00 0.00

Portfolios with RGLS

Latest RGLS Headlines from TheStreet

More Financial News for RGLS

Press Releases for RGLS

See All Press Releases

Partner Headlines for RGLS

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter